Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium

Publication date

2024-10

Authors

Botrugno, Carlo
Crico, Chiara
Iori, Mauro
Blanck, Oliver
Blamek, Slawomir
Postema, Pieter G.
Quesada, Aurelio
Pruvot, Etienne
Verhoeff, J. J.C.ORCID 0000-0001-9673-0793ISNI 0000000393929005
De Panfilis, Ludovica

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

This preliminary ethical appraisal from the STOPSTORM.eu consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia radioablation should consider to meet the highest standards in medical ethics and thus promote quality of life of patients recruited for radiotherapy treatments at a stage in which they experience a significant degree of vulnerability.

Keywords

Bioethics, Cardiovascular disease, Ethics in research, Stereotactic Body Radiotherapy, Ventricular tachycardia, Radiology Nuclear Medicine and imaging, Oncology

Citation

Botrugno, C, Crico, C, Iori, M, Blanck, O, Blamek, S, Postema, P G, Quesada, A, Pruvot, E, Verhoeff, J J C & De Panfilis, L 2024, 'Patient vulnerability in stereotactic arrhythmia radioablation (STAR) : a preliminary ethical appraisal from the STOPSTORM.eu consortium', Strahlentherapie und Onkologie, vol. 200, no. 10, pp. 903-907. https://doi.org/10.1007/s00066-024-02230-w